Search
Returning search results with filters:
Remove filter for
Audience: Healthcare
Remove filter for
Type: Public advisory
Clear all
Type
Audience
Category
Issue
Last updated
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archived checkbox.
Displaying 1 - 15 of 39 items.
Misuse or modification of lithium-ion batteries in e-mobility devices can be extremely dangerous
There has been a reported increase in e-mobility device battery fires across North America over the last few years.
In the United States, between January 1, 2021, and November 28, 2022, the Consumer Products Safety Commission (CPSC) received reports…
AlertPublic advisory | 2023-05-11
Shortage of Nitroglycerin Sprays and Tablets in Canada
May 10, 2023 – Shortage of Nitroglycerin Tablets
Canada is experiencing a shortage of nitroglycerin tablets due to an increase in demand caused by the nitroglycerin spray shortage. Nitroglycerin tablets are placed under the tongue and are used to…
AlertPublic advisory | 2023-05-10
Canadian labelling for all JAK inhibitors to include risks of serious heart-related problems, fatal blood clots and cancer
The Canadian labelling for all Janus Kinase (JAK) inhibitors is being updated to include the risks of serious heart-related problems, fatal blood clots and cancer. This is being done as a precautionary measure. To date, Canadian labelling for the drugs…
AlertPublic advisory | 2022-11-01
Recall of one lot of pms-Hydromorphone due to packaging error that could potentially lead to overdose
Pharmascience Inc. is recalling one lot of pms-Hydromorphone, 2 mg tablets, (lot 639268) as the bottles may contain hydromorphone tablets of a different strength (8 mg), meaning they contain higher amounts of hydromorphone. Products from the affected lot…
AlertPublic advisory | 2022-08-20
Updated safety review of breast implants underscores the continuing importance of monitoring for cancer; increased risk with highly textured (macro-textured) implants
Health Canada has updated its 2019 and 2017 safety reviews on breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), a rare but serious cancer of the immune system that can develop next to a breast implant. This review found that there…
AlertPublic advisory | 2022-04-06
Lichtenberg generators pose life-threatening danger to users
Health Canada is aware of six reports of fatal injuries in Canada since 2017 resulting from the use of wood-burning devices know as Lichtenberg generators. This information was reported from provincial and territorial electrical safety authorities.…
AlertPublic advisory | 2022-01-19
Health Canada safety review finds link between the use of Xeljanz and Xeljanz XR (tofacitinib) and increased risk of serious heart-related issues and cancer
UPDATE - January 12, 2022: Safety Review found a link between the use of Xeljanz/Xeljanz XR (tofacitinib) and the risks of serious heart-related problems and cancer
Health Canada completed a safety review that confirmed a link between the use of…
AlertPublic advisory | 2022-01-12
Potential contamination of health products manufactured by Eco-Med Pharmaceuticals Inc. may pose health risks to Canadians
As a precaution, Health Canada is advising Canadians to stop using and discard all products manufactured by Eco-Med Pharmaceuticals (ultrasound gels, transmission and massage lotions, hand sanitizers and first aid antiseptics) due to potential bacterial…
AlertPublic advisory | 2021-12-20
Ivermectin not authorized to prevent or treat COVID-19; may cause serious health problems
UPDATE (October 19, 2021): Reports to poison centres concerning ivermectin as a prevention or treatment for COVID-19 have increased over the summer months
Health Canada is reminding Canadians not to use ivermectin to prevent or treat COVID-19.…
AlertPublic advisory | 2021-10-19
Recall: One lot of Riva-Risperidone 0.25 mg tablets recalled due to a packaging error
Recall: One lot of Riva-Risperidone 0.25 mg tablets recalled due to a packaging error
Starting date:
October 9, 2021
Type of communication:
Advisory
Subcategory:
Drugs
Source…
AlertPublic advisory | 2021-10-09
Two lots of Novo-Gesic Forte/Acetaminophen recalled due to labelling error that may lead to overdose and in the most severe cases, death
Two lots of Novo-Gesic Forte/Acetaminophen recalled due to labelling error that may lead to overdose and in the most severe cases, death
Starting date:
October 6, 2021
Type of…
AlertPublic advisory | 2021-10-06
One lot of Mirvala 28 birth control pill recalled
One lot of Mirvala 28 birth control pill recalled
Starting date:
September 30, 2021
Posting date:
September 30, 2021
Type of communication:
Advisory
Subcategory:
Drugs
Source…
AlertPublic advisory | 2021-09-30
Graphene face masks
Graphene face masks
Starting date:
July 13, 2021
Posting date:
September 28, 2021
Type of communication:
Advisory
Subcategory:
Medical Device
Source of recall:
Health Canada…
AlertPublic advisory | 2021-09-28
One lot of the hypoglycemia treatment Glucagon recalled as it may pose serious health risks
One lot of the hypoglycemia treatment Glucagon recalled as it may pose serious health risks
Starting date:
September 25, 2021
Posting date:
September 25, 2021
Type of…
AlertPublic advisory | 2021-09-25
Health Canada updates Pfizer-BioNTech COVID-19 vaccine label to reflect very rare reports of Bell's Palsy
Health Canada updates Pfizer-BioNTech COVID-19 vaccine label to reflect very rare reports of Bell's Palsy
Starting date:
August 6, 2021
Type of communication:
Advisory…
AlertPublic advisory | 2021-08-06